- Home
- ET vs COR Comparison
ET vs COR Comparison
Compare ET & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ET | COR |
|---|---|---|
| Founded | 2002 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Other Pharmaceuticals |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.8B | 59.0B |
| IPO Year | 2005 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ET | COR |
|---|---|---|
| Price | $21.15 | $310.58 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 14 |
| Target Price | $21.67 | ★ $390.62 |
| AVG Volume (30 Days) | ★ 7.0M | 1.0M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.83% | 0.77% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | N/A | ★ 15.21 |
| Revenue | $85,536,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $20.84 | $8.89 |
| Revenue Next Year | $4.61 | $6.75 |
| P/E Ratio | ★ $15.59 | $20.34 |
| Revenue Growth | 3.47 | ★ 9.31 |
| 52 Week Low | $16.18 | $244.82 |
| 52 Week High | $21.84 | $377.54 |
Technical Indicators
Market Signals| Indicator | ET | COR |
|---|---|---|
| Relative Strength Index (RSI) | 51.49 | 40.89 |
| Support Level | $20.96 | $308.48 |
| Resistance Level | $21.75 | $312.18 |
| Average True Range (ATR) | 0.30 | 6.59 |
| MACD | -0.09 | -2.57 |
| Stochastic Oscillator | 32.58 | 17.75 |
Price Performance
Historical ComparisonAbout ET Energy Transfer LP
Energy Transfer is a diversified midstream firm operating from wellhead to consuming demand. It handles natural gas, natural gas liquids, crude oil, and refined products. Commodities are moved through its network of field-level gathering and processing to refineries and demand centers. Operations are concentrated in Texas and the midcontinent United States. It also controls Sunoco and USA Compression through its general partner relationship.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.